France jurisdiction report: Good news for parallel importers

18-09-2018

Aurélia Marie

France jurisdiction report: Good news for parallel importers

julnichols / iStockphoto.com

Parallel importation of pharmaceuticals in the EU has, for a long time, raised many issues. National constraints require the parallel importer to modify the presentation of the products in order to comply with national laws, and the trademark owner has tried to make use of such alteration to oppose the commercialisation of the goods that were escaping its distribution network in that way.


France jurisdiction report, parallel importers, Aurélia Marie, packaging, pharmaceuticals, labelling, distribution, medical use, commercialiation, brand

WIPR